Ocular Effects of the Venom from the Spitting Cobra (Naja Nigricollis)

References

• Gomes B. External opthalmoplegia from snake poison. Opthalmol. 1943; 3: 187
   Google Scholar
• Gilkes M. J. Snake venom conjunctivitis. Br. J. Opthalmol. 1959; 43: 628
   Google Scholar
• Montgomery J. Two cases of opthalmoplegia due to adder bite. Cent. Afr. J. Med. 1959; 5: 173
   PubMedGoogle Scholar
• Moeller W., Tost M. Beitrag zur Viparet Unvertraeglichkeit am Auge. Deutsch Gesundh 1968; 23: 2027
   PubMedGoogle Scholar
• Sinha A. K. Cobra venom conjunctivitis. Lancet 1972; 1: 1026
   PubMed Web of Science ®Google Scholar
• The Reptiles and Amphibians of South Africa, W. Rose. Maskew Miller, Cape Town 1950
   Google Scholar
• Chapman D. S. The symptomatology, pathology and treatment of the bites of venomous snakes of Central and Southern Africa. Venomous Animals and their Venoms, Vol. I, Venomous Vertebrates, W. Bucherl, E. E. Buckley, V. Deulofeu. Academic Press, New York 1968; 463
   Google Scholar
• Strover H. M. Observations on two cases of snake-bite by Naja nigricollis SS mossambica. Cent. Afr. J. Med. 1973; 19: 12
   PubMedGoogle Scholar
• Snakes of Southern Africa, V. F.M. Fitzsimons. Purnell, Cape Town 1962
   Google Scholar
• South African Snake Venoms and Antivenins, P. A. Christensen. S. Afr. Inst. Med. Res., Johannesburg 1955
   Google Scholar
• Khalil M. Snake bite. Bull. Opthalmol. Sco. Egypt 1958; 51: 687
   Google Scholar
• Millodot M. Do blue-eyed people have more sensitive corneas than brown-eyed people. Nature 1975; 255: 151
   PubMed Web of Science ®Google Scholar
• Millodot M. The sensitivity of the cornea in normal eyes. Frontiers in Visual Sciences, S. J. Cool, E. L. Smith. Springer-Verlag, New York 1978; 11
   Google Scholar
• Potts A. M. The concentration of phenothiazines in the eyes of experimental animals. Invest. Opthalmol. 1962; 1: 522
   PubMedGoogle Scholar
• Potts A. M. Further studies concerning the accumulation of polycyclic compounds on uveal melanin. Invest. Opthalmol. 1964; 3: 399
   PubMedGoogle Scholar
• McChesney E. W., Banks W. F., Jr., Sullivan D. J. Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats. Toxicol. Appl. Pharmac. 1965; 7: 627
   PubMed Web of Science ®Google Scholar
• Ismail M., Abdullah M. E., Morad A. M., Ageel A. M. Pharmacokinetics of 125I-labelled venom from the scorpion Androctonus amoreuxi. Aud. and Sav Toxicon 1980; 18: 301
   PubMed Web of Science ®Google Scholar
• Sokal R. R., Rohlf F. J. Biometry, The Principles and Practice of Statistics in Biological Research2nd ed. W.H. Freeman and Co., San Francisco 1981; 429
   Google Scholar
• Osman O. H., Ismail M., Karrar M. A. Acetylcholine release from the nerve terminals of the guinea-pig ileum by Naja venoms. Toxicon 1976; 14: 127
   PubMed Web of Science ®Google Scholar
• Osman O. H., El-Khawad A. O.A., Ismail M. Hypothermic effect in rats of Naja nigricollis venom: Role of acetylcholine. Toxicon 1977; 15: 75
   PubMed Web of Science ®Google Scholar
• Christensen P. A. The venoms of Central and Southern African snakes. Venomous animals and their Venoms, Vol. I, Venomous Vertebrates, W. Bucherl, E. E. Buckley, V. Deulofeu. Academic Press, New York 1968; 437
   Google Scholar
• Wahlstrom A. Purification and characterization of phospholipase A from Naja nigricollis venom. Toxicon 1971; 9: 46
   Google Scholar
• Hogberg B., Uvnas B. Further Observation on the disruption of rat mesentry mast cells caused by compound 48/80, antigen-antibody reaction, lecithinase and decylamine. Acta Physiol. Scand. 1960; 48: 133
   PubMedGoogle Scholar
• Mohamed A. H., El-Seroughi M. S., Hamed R. M. Effects of Naja nigricollis venom on histamine of blood and tissues. Toxicon 1971; 9: 169
   PubMed Web of Science ®Google Scholar
• Gartner S. Conjunctival vessels. Arch. Opthalmol. 1944; 32: 464
   Google Scholar
• Herrman H. Histamine. Bull. Johns Hopkins Hosp. 1944; 82: 208
   Google Scholar
• Fitzgerald G. G., Cooper J. R. Acetylcholine as a possible sensory mediator in rabbit corneal epthelium. Biochem. Pharmac. 1971; 20: 2741
   PubMed Web of Science ®Google Scholar
• Howard R. O., Wilson W. S., Dunn B. Quantitative determination of choline acetylase, acetylcholine and acetylcholinesterase in the developing rabbit cornea. Invest. Opthalmol. 1973; 12: 418
   PubMedGoogle Scholar
• Zadunaisky J. A., Spinowitz B. Drugs affecting the transport and permeability of the corneal epithelium. Drugs and Ocular Tissues Second Meeting of the International Society for Eye Research. 1977, S. Dikstein. Karger, Basel, 57
   Google Scholar
• Braganca B. M., Quastel J. H. The action of snake venom on acetylcholine synthesis in the brain. Nature (London) 1952; 169: 695
   PubMed Web of Science ®Google Scholar
• Opthalmic Pathology, An Atlas and Text Book2nd ed., M. J. Hogan, L. E. Zimmerman. Saunders, Philadelphia and London 1962; 294
   Google Scholar
• Fisher E., Jr., Allen J. H. Mechanism of Corneal destruction by Pseudomonas proteases. Am. J. Opthalmol. 1958; 46: 249
   PubMed Web of Science ®Google Scholar
• Brown S. I., Weller C. A. Collagenase inhibitors in prevention of ulcers of alkali-burned corneas. Opthalmol. 1970; 83: 252
   Web of Science ®Google Scholar
• Brown S. I., Bloomfield S. E., Tam W. I. The cornea destroying enzyme of pseudomonas aeruginosa. Invest. Opthalmol. 1974; 13: 174
   PubMedGoogle Scholar
• Eagle H. The coagulation of blood by snake venoms and its physiological significance. J. Exptl. Med. 1937; 65: 613
   PubMedGoogle Scholar
• Zeller E. A. Enzymes of snake venoms and their biological significance. Adv. Enzymol. 1948; 8: 459
   Google Scholar
• Zeller E. A. Enzymes as essential components of toxins. The Enzymes, J. B. Summer, K. Myrback. Academic Press, New York 1951; Vol. I: 1010, Part II
   Google Scholar
• Ellison A. C., Poirier R. Therapeutic effect of heparin on pseudomonas-induced corneal ulceration. Am. J. Opthalmol. 1976; 82: 619
   PubMed Web of Science ®Google Scholar
• Aronson S. B., Elliot J. H., Moore T. E., Jr., O'Day D. M. Pathogenetic approach to therapy of peripheral corneal inflammatory disease. Am. J. Opthalmol. 1970; 70: 65
   PubMed Web of Science ®Google Scholar
• Brown S. I., Hook C. W. Treatment of corneal destruction with collagenase inhibitors. Trans, Am. Acad. Opthalmol. Otolaryngol 1971; 75: 1199
   PubMedGoogle Scholar
• Berman M. B., Manabe R. Corneal collagenase: Evidence for zinc metallo enzymes. Opthalmol. 1973; 5: 1193
   Google Scholar
• Backer B. The side effects of corticosteroids. Invest. Opthalmol. 1964; 3: 492
   PubMedGoogle Scholar
• Crews S. J. Adverse reactions to corticosteroid therapy in the eye. Proc. R. Soc. Med. 1965; 58: 533
   PubMedGoogle Scholar
• David D. S., Berkowitz J. S. ocular effects of topical and systemic corticosteroids. Lancet 1969; 2: 149
   PubMed Web of Science ®Google Scholar
• Drug-Induced Ocular Side Effects and Drug Interactions, F. T. Fraunfelder. Lea and Fabiger, Philadelphia 1976; 182
   Google Scholar